BRNS

MKT CAP:$29M

Barinthus Biotherapeutics plc

Market Cap

$29M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$0.65-$0.08 (-11.29%)

Jun 5, 2026

52W High $1.9752W Low $0.54

Company Details

Barinthus Biotherapeutics plc, together with its subsidiaries, engages in the research, development, and commercialization of immunotherapies and vaccines in the United States and the United Kingdom. The company develops VTP-1000, an antige...

CEO

—

IPO Date

Apr 30, 2021

Website

www.barinthusbio.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$52M

EPS (Diluted)

Free Cash Flow

-$36M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

Apr 30, 2026

FY 2025

Mar 13, 2026

$0-100.0%

Q4 2025

Mar 13, 2026

$0+100.0%

Q3 2025

Nov 7, 2025

$0-100.0%

Q2 2025

Aug 7, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee